Companies with a Future performance score of at least 3, ordered by Future performance score.
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally.
Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden.
Genovis AB (publ.) develops, produces, and sells tools for developing drugs for customers in the medical device and pharmaceutical industries.
Cellink AB (publ) designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications primarily in pharmaceutical to cosmetic industries worldwide.
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
Camurus AB (publ), a pharmaceutical company, develops and commercializes pharmaceuticals for serious and chronic conditions in Europe, North America, and Asia.
BioInvent International AB (publ) focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
Intervacc AB (publ), a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health.
RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of diseases in wound and dental care in Sweden.
Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden.
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, distributes, and sells healthcare products.
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases.
Immunicum AB (publ) develops therapeutic cancer vaccines.
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based therapies for serious diseases.
Probi AB (publ), a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies.
Recipharm AB (publ) provides contract development and manufacturing solutions to the pharmaceutical industry in Sweden, Italy, France, India, Spain, Portugal, Germany, and internationally.